Based on a report from FMI, the global allergy immunotherapy market is projected to attain a valuation of approximately $1.74 billion by the year 2023. Furthermore, it is anticipated to exhibit robust growth, surpassing $4.07 billion by 2033, with a compound annual growth rate (CAGR) of 8.9% during the forecast period spanning from 2023 to …